Equities

Astena Holdings Co Ltd

8095:TYO

Astena Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)506.00
  • Today's Change1.00 / 0.20%
  • Shares traded215.60k
  • 1 Year change-1.75%
  • Beta0.5866
Data delayed at least 20 minutes, as of Nov 14 2024 05:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Nov 30 2023202320222021
OPERATIONS
Net income1,5601,4183,079
Depreciation/depletion2,2162,1181,830
Non-Cash items42(358)(688)
Cash taxes paid, supplemental1,3531,115946
Cash interest paid, supplemental605461
Changes in working capital(2172)(3918)(2872)
Total cash from operations1,646(740)1,349
INVESTING
Capital expenditures(4165)(3030)(3494)
Other investing and cash flow items, total1,330808(886)
Total cash from investing(2835)(2222)(4380)
FINANCING
Financing cash flow items111749.61
Total cash dividends paid(719)(729)(651)
Issuance (retirement) of stock, net(0.06)(278)4,186
Issuance (retirement) of debt, net1,686(160)2,808
Total cash from financing1,078(1093)6,353
NET CHANGE IN CASH
Foreign exchange effects665337
Net change in cash(46)(4003)3,359
Net cash-begin balance/reserved for future use6,80410,8077,448
Net cash-end balance/reserved for future use6,7586,80410,807
SUPPLEMENTAL INCOME
Depreciation, supplemental2,2162,1181,830
Cash interest paid, supplemental605461
Cash taxes paid, supplemental1,3531,115946
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.